buthionine sulfoximine has been researched along with oxidopamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fornstedt, B; Magnusson, T; Pileblad, E | 1 |
| Jenner, P; Marsden, CD; Seaton, TA | 1 |
| Jenner, P; McNaught, KS | 1 |
| Choi, HY; Park, DK; Ross, GM; Song, JH | 1 |
| Hashimoto, K; Iyo, M; Komatsu, N; Shimizu, E | 1 |
| Leak, RK; Liou, AK; Zigmond, MJ | 1 |
| Gangaraju, S; Gardaneh, M; Iwasiow, R; Kiuchi, K; Lanthier, P; Ribecco-Lutkiewicz, M; Sandhu, JK; Sikorska, M; Tremblay, R | 1 |
| Chang, SW; Chen, JH; Lin, CY; Lin, FJ; Ou, HP; Tsai, CW; Wu, CR | 1 |
| Gunjima, K; Hashida, K; Hori, O; Konishi, T; Matsugo, S; Nakamura, Y; Takakura, K; Tomiyama, R; Yamada, T | 1 |
| Bonilla-Porras, AR; Jimenez-Del-Rio, M; Velez-Pardo, C | 1 |
10 other study(ies) available for buthionine sulfoximine and oxidopamine
| Article | Year |
|---|---|
Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.
Topics: Animals; Buthionine Sulfoximine; Corpus Striatum; Dopamine; Drug Synergism; Glutathione; Hydroxydopamines; Injections, Intraventricular; Male; Methionine Sulfoximine; Norepinephrine; Oxidation-Reduction; Oxidopamine; Rats; Rats, Inbred Strains | 1989 |
Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain.
Topics: Animals; Antimetabolites; Biogenic Monoamines; Brain; Brain Chemistry; Buthionine Sulfoximine; Chromatography, High Pressure Liquid; Glutathione; Immunohistochemistry; Male; Neostriatum; Oxidopamine; Rats; Rats, Wistar; Sympatholytics; Thioctic Acid; Tyrosine 3-Monooxygenase | 1996 |
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Astrocytes; Buthionine Sulfoximine; Cells, Cultured; Coculture Techniques; Dizocilpine Maleate; Dopamine; Electron Transport Complex I; Excitatory Amino Acid Antagonists; Glutathione; Lipopolysaccharides; Mesencephalon; NADH, NADPH Oxidoreductases; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 1999 |
The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics.
Topics: Animals; Ascorbic Acid; Buthionine Sulfoximine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Pharmacokinetics; Rats | 2000 |
Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells.
Topics: Acetylcysteine; Apoptosis; Benzimidazoles; Brain Neoplasms; Buthionine Sulfoximine; Cystine; DNA Fragmentation; Fluorescent Dyes; Free Radical Scavengers; Glutathione; Humans; Neuroblastoma; Neurons; Oxidopamine; Sympatholytics; Tumor Cells, Cultured | 2002 |
Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism.
Topics: Adaptation, Biological; Adrenergic Agents; Animals; Buthionine Sulfoximine; Catalase; Cell Survival; Cysteine Proteinase Inhibitors; Dopamine; Enzyme Inhibitors; Glutathione; Leupeptins; Oxidative Stress; Oxidopamine; PC12 Cells; Proteasome Endopeptidase Complex; Rats; RNA, Small Interfering; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2008 |
Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity.
Topics: Analysis of Variance; Animals; Antioxidants; Astrocytes; Blotting, Western; Buthionine Sulfoximine; Cell Survival; Coculture Techniques; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Glutathione; Humans; Immunohistochemistry; Mice; Neurons; Oxidopamine; Polymerase Chain Reaction; Signal Transduction; Transfection | 2009 |
Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis.
Topics: Abietanes; Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Line; Down-Regulation; Glutamate-Cysteine Ligase; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; Oxidopamine; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles | 2012 |
3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
Topics: Buthionine Sulfoximine; Caffeic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Glutathione; Humans; Neuroblastoma; Neuroprotective Agents; Neurotoxins; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Protein Transport; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2014 |
N-acetyl-cysteine blunts 6-hydroxydopamine- and L-buthionine-sulfoximine-induced apoptosis in human mesenchymal stromal cells.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Death; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mesenchymal Stem Cells; Oxidation-Reduction; Oxidative Stress; Oxidopamine; Reactive Oxygen Species | 2019 |